Your browser doesn't support javascript.
loading
P17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell-line activation.
Duraisamy, Karthi; Singh, Kailash; Kumar, Mukesh; Lefranc, Benjamin; Bonnafé, Elsa; Treilhou, Michel; Leprince, Jérôme; Chow, Billy K C.
Afiliação
  • Duraisamy K; School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
  • Singh K; School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
  • Kumar M; School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
  • Lefranc B; INSERM U1239, PRIMACEN, IRIB, Normandy University, Rouen, France.
  • Bonnafé E; EA7417 BTSB, Université Fédérale Toulouse Midi-Pyrénées, INU Champollion, Albi, France.
  • Treilhou M; EA7417 BTSB, Université Fédérale Toulouse Midi-Pyrénées, INU Champollion, Albi, France.
  • Leprince J; INSERM U1239, PRIMACEN, IRIB, Normandy University, Rouen, France. Electronic address: jerome.leprince@univ-rouen.fr.
  • Chow BKC; School of Biological Sciences, The University of Hong Kong, Hong Kong, China. Electronic address: bkcc@hku.hk.
J Allergy Clin Immunol ; 149(1): 275-291, 2022 01.
Article em En | MEDLINE | ID: mdl-34111449
ABSTRACT

BACKGROUND:

P17, a peptide isolated from Tetramorium bicarinatum ant venom, is known to induce an alternative phenotype of human monocyte-derived macrophages via activation of an unknown G protein-coupled receptor (GPCR).

OBJECTIVE:

We sought to investigate the mechanism of action and the immunomodulatory effects of P17 mediated through MRGPRX2 (Mas-related G protein-coupled receptor X2).

METHODS:

To identify the GPCR for P17, we screened 314 GPCRs. Upon identification of MRGPRX2, a battery of in silico, in vitro, ex vivo, and in vivo assays along with the receptor mutation studies were performed. In particular, to investigate the immunomodulatory actions, we used ß-hexosaminidase release assay, cytokine releases, quantification of mRNA expression, cell migration and differentiation assays, immunohistochemical labeling, hematoxylin and eosin, and immunofluorescence staining.

RESULTS:

P17 activated MRGPRX2 in a dose-dependent manner in ß-arrestin recruitment assay. In LAD2 cells, P17 induced calcium and ß-hexosaminidase release. Quercetin- and short hairpin RNA-mediated knockdown of MRGPRX2 reduced P17-evoked ß-hexosaminidase release. In silico and in vitro mutagenesis studies showed that residue Lys8 of P17 formed a cation-π interaction with the Phe172 of MRGPRX2 and [Ala8]P17 lost its activity partially. P17 activated LAD2 cells to recruit THP-1 and human monocytes in Transwell migration assay, whereas MRGPRX2-impaired LAD2 cells cannot. In addition, P17-treated LAD2 cells stimulated differentiation of THP-1 and human monocytes, as indicated by the enhanced expression of macrophage markers cluster of differentiation 11b and TNF-α by quantitative RT-PCR. Immunohistochemical and immunofluorescent staining suggested monocyte recruitment in mice ears injected with P17.

CONCLUSIONS:

Our data provide novel structural information regarding the interaction of P17 with MRGPRX2 and intracellular pathways for its immunomodulatory action.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Receptores Acoplados a Proteínas G Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Receptores Acoplados a Proteínas G Idioma: En Ano de publicação: 2022 Tipo de documento: Article